649 related articles for article (PubMed ID: 33679322)
1. Emerging Evidence Highlighting the Importance of Redox Dysregulation in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS).
Jagaraj CJ; Parakh S; Atkin JD
Front Cell Neurosci; 2020; 14():581950. PubMed ID: 33679322
[TBL] [Abstract][Full Text] [Related]
2. Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases.
Shadfar S; Parakh S; Jamali MS; Atkin JD
Transl Neurodegener; 2023 Apr; 12(1):18. PubMed ID: 37055865
[TBL] [Abstract][Full Text] [Related]
3. Redox regulation in amyotrophic lateral sclerosis.
Parakh S; Spencer DM; Halloran MA; Soo KY; Atkin JD
Oxid Med Cell Longev; 2013; 2013():408681. PubMed ID: 23533690
[TBL] [Abstract][Full Text] [Related]
4. The Redox Activity of Protein Disulfide Isomerase Inhibits ALS Phenotypes in Cellular and Zebrafish Models.
Parakh S; Shadfar S; Perri ER; Ragagnin AMG; Piattoni CV; Fogolín MB; Yuan KC; Shahheydari H; Don EK; Thomas CJ; Hong Y; Comini MA; Laird AS; Spencer DM; Atkin JD
iScience; 2020 May; 23(5):101097. PubMed ID: 32446203
[TBL] [Abstract][Full Text] [Related]
5. Nuclear SOD1 in Growth Control, Oxidative Stress Response, Amyotrophic Lateral Sclerosis, and Cancer.
Xu J; Su X; Burley SK; Zheng XFS
Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204309
[TBL] [Abstract][Full Text] [Related]
6. Protein disulphide isomerase is associated with mutant SOD1 in canine degenerative myelopathy.
Chang RC; Parakh S; Coates JR; Long S; Atkin JD
Neuroreport; 2019 Jan; 30(1):8-13. PubMed ID: 30422940
[TBL] [Abstract][Full Text] [Related]
7. ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis.
Parakh S; Jagaraj CJ; Vidal M; Ragagnin AMG; Perri ER; Konopka A; Toth RP; Galper J; Blair IP; Thomas CJ; Walker AK; Yang S; Spencer DM; Atkin JD
Hum Mol Genet; 2018 Apr; 27(8):1311-1331. PubMed ID: 29409023
[TBL] [Abstract][Full Text] [Related]
8. RNA Dysregulation in Amyotrophic Lateral Sclerosis.
Butti Z; Patten SA
Front Genet; 2018; 9():712. PubMed ID: 30723494
[TBL] [Abstract][Full Text] [Related]
9. AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.
Perera ND; Turner BJ
Neurochem Res; 2016 Mar; 41(3):544-53. PubMed ID: 26202426
[TBL] [Abstract][Full Text] [Related]
10. In vivo EPR pharmacokinetic evaluation of the redox status and the blood brain barrier permeability in the SOD1
Stamenković S; Pavićević A; Mojović M; Popović-Bijelić A; Selaković V; Andjus P; Bačić G
Free Radic Biol Med; 2017 Jul; 108():258-269. PubMed ID: 28366802
[TBL] [Abstract][Full Text] [Related]
11. Protein Disulphide Isomerases: emerging roles of PDI and ERp57 in the nervous system and as therapeutic targets for ALS.
Perri E; Parakh S; Atkin J
Expert Opin Ther Targets; 2017 Jan; 21(1):37-49. PubMed ID: 27786579
[TBL] [Abstract][Full Text] [Related]
12. Misregulation of iron homeostasis in amyotrophic lateral sclerosis.
Gajowiak A; Styś A; Starzyński RR; Staroń R; Lipiński P
Postepy Hig Med Dosw (Online); 2016 Jun; 70(0):709-21. PubMed ID: 27356602
[TBL] [Abstract][Full Text] [Related]
13. Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies.
Yang X; Ji Y; Wang W; Zhang L; Chen Z; Yu M; Shen Y; Ding F; Gu X; Sun H
Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34202494
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS.
Carrì MT; Valle C; Bozzo F; Cozzolino M
Front Cell Neurosci; 2015; 9():41. PubMed ID: 25741238
[TBL] [Abstract][Full Text] [Related]
16. Redox regulation of cellular stress response in neurodegenerative disorders.
Calabrese V; Guagliano E; Sapienza M; Mancuso C; Butterfield DA; Stella AM
Ital J Biochem; 2006; 55(3-4):263-82. PubMed ID: 17274531
[TBL] [Abstract][Full Text] [Related]
17. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies.
Beers DR; Appel SH
Lancet Neurol; 2019 Feb; 18(2):211-220. PubMed ID: 30663610
[TBL] [Abstract][Full Text] [Related]
18. Cellular Redox Systems Impact the Aggregation of Cu,Zn Superoxide Dismutase Linked to Familial Amyotrophic Lateral Sclerosis.
Álvarez-Zaldiernas C; Lu J; Zheng Y; Yang H; Blasi J; Solsona C; Holmgren A
J Biol Chem; 2016 Aug; 291(33):17197-208. PubMed ID: 27261461
[TBL] [Abstract][Full Text] [Related]
19. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis.
Poon HF; Hensley K; Thongboonkerd V; Merchant ML; Lynn BC; Pierce WM; Klein JB; Calabrese V; Butterfield DA
Free Radic Biol Med; 2005 Aug; 39(4):453-62. PubMed ID: 16043017
[TBL] [Abstract][Full Text] [Related]
20. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
Hayashi Y; Homma K; Ichijo H
Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
